Benzenes

<p>2,5-Dichlorobenzonitrile is a chemical compound that contains a nitrile group. It is used as an intermediate in organic synthesis, as well as for the production of various pharmaceuticals and pesticides. 2,5-Dichlorobenzonitrile is oxidized to form 2,5-dichlorophenol which can be further converted to 2,5-dichloroquinone. This redox cycle is reversible and can be used to synthesize other compounds. The reaction time of this process is about one hour at room temperature. Maleate has been shown to inhibit the hepatic metabolism of 2,5-Dichlorobenzonitrile. This may lead to accumulation of 2,5-Dichlorobenzonitrile in the liver and potentially cause hepatitis or even liver cancer. Chloromethylation of 2,5-Dichlorobenzonitrile leads to the formation of chlor</p>

<p>3-Amino-5-bromobenzoic acid is a synthetic, water soluble anti-inflammatory agent. It is cytotoxic to macrophages in vitro and has significant efficacy in vivo. Its mechanism of action is to inhibit the synthesis of nucleotides in the cell. 3-Amino-5-bromobenzoic acid also inhibits inflammation by inhibiting prostaglandin synthesis and has been shown to be effective against seborrheic dermatitis. This drug has pharmacokinetic properties that are favourable for oral administration and is rapidly absorbed from the gastrointestinal tract with a half life of 2 hours. The drug is eliminated through the kidneys, with an elimination half life of 6 hours.</p>

<p>3,4-Difluorobenzaldehyde is a chemical inhibitor that has been shown to be effective in the treatment of cancer. It inhibits the activity of an enzyme called tyrosine kinase by reacting with its functional group, leading to decreased production of growth factors and cell proliferation. 3,4-Difluorobenzaldehyde has been shown to have a high reaction yield in animal health studies, and it can be used as a drug for treating carcinoma cells. This compound also has strong liquid crystal properties and can be used as a component of diphenyl ether molecules. 3,4-Difluorobenzaldehyde is metabolized by the liver or excreted through urine. The pharmacokinetic properties of this compound are similar to those of other drugs that are metabolized by humans.</p>

<p>2-Amino-3-fluorobenzoic acid methyl ester (2AFBME) is an antibacterial agent that inhibits bacterial protein synthesis by binding to ribosomes and inhibiting the release of amino acids during translation. 2AFBME has been shown to have antibacterial activity against aureus, streptococcus, and staphylococcus strains in laboratory tests. The clinical development of 2AFBME has not yet been completed.</p>

<p>M03191 - Boc-4-Nitro-phenylalanine</p>

<p>M03220 - Boc-4-Nitro-D-phenylalanine</p>